|
Lianhe Chemical Technology Co., Ltd. (002250.SZ) Valoración de DCF
CN | Basic Materials | Chemicals - Specialty | SHZ
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Lianhe Chemical Technology Co., Ltd. (002250.SZ) Bundle
¡Evalúe las perspectivas financieras de Lianhe Chemical Technology Co., Ltd. como un experto! Esta calculadora DCF (002250SZ) le proporciona datos financieros precipitados, al tiempo que le permite personalizar el crecimiento de los ingresos, WACC, los márgenes y otros supuestos esenciales para alinearse con sus proyecciones.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4,283.8 | 4,781.8 | 6,586.8 | 7,865.5 | 6,442.2 | 7,258.5 | 8,178.4 | 9,214.8 | 10,382.5 | 11,698.2 |
| Revenue Growth, % | 0 | 11.63 | 37.75 | 19.41 | -18.1 | 12.67 | 12.67 | 12.67 | 12.67 | 12.67 |
| EBITDA | 831.4 | 759.4 | 1,055.1 | 1,646.0 | 492.0 | 1,159.5 | 1,306.4 | 1,472.0 | 1,658.5 | 1,868.7 |
| EBITDA, % | 19.41 | 15.88 | 16.02 | 20.93 | 7.64 | 15.97 | 15.97 | 15.97 | 15.97 | 15.97 |
| Depreciation | 446.2 | 480.3 | 571.1 | 594.9 | 775.3 | 707.4 | 797.0 | 898.0 | 1,011.8 | 1,140.0 |
| Depreciation, % | 10.41 | 10.04 | 8.67 | 7.56 | 12.03 | 9.75 | 9.75 | 9.75 | 9.75 | 9.75 |
| EBIT | 385.3 | 279.1 | 484.0 | 1,051.1 | -283.3 | 452.1 | 509.4 | 574.0 | 646.7 | 728.7 |
| EBIT, % | 8.99 | 5.84 | 7.35 | 13.36 | -4.4 | 6.23 | 6.23 | 6.23 | 6.23 | 6.23 |
| Total Cash | 970.3 | 635.6 | 561.0 | 583.2 | 661.4 | 902.1 | 1,016.4 | 1,145.2 | 1,290.3 | 1,453.9 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 1,055.7 | 1,244.8 | 1,787.8 | 1,878.8 | 1,464.4 | 1,806.4 | 2,035.3 | 2,293.3 | 2,583.9 | 2,911.3 |
| Account Receivables, % | 24.64 | 26.03 | 27.14 | 23.89 | 22.73 | 24.89 | 24.89 | 24.89 | 24.89 | 24.89 |
| Inventories | 1,625.3 | 1,859.8 | 2,252.8 | 2,910.5 | 2,619.6 | 2,739.4 | 3,086.5 | 3,477.7 | 3,918.4 | 4,414.9 |
| Inventories, % | 37.94 | 38.89 | 34.2 | 37 | 40.66 | 37.74 | 37.74 | 37.74 | 37.74 | 37.74 |
| Accounts Payable | 719.3 | 1,680.0 | 2,676.5 | 2,915.9 | 1,779.5 | 2,282.9 | 2,572.1 | 2,898.1 | 3,265.4 | 3,679.2 |
| Accounts Payable, % | 16.79 | 35.13 | 40.63 | 37.07 | 27.62 | 31.45 | 31.45 | 31.45 | 31.45 | 31.45 |
| Capital Expenditure | -1,113.6 | -1,462.4 | -1,645.2 | -1,730.7 | -1,055.1 | -1,741.2 | -1,961.8 | -2,210.4 | -2,490.5 | -2,806.1 |
| Capital Expenditure, % | -26 | -30.58 | -24.98 | -22 | -16.38 | -23.99 | -23.99 | -23.99 | -23.99 | -23.99 |
| Tax Rate, % | -16.09 | -16.09 | -16.09 | -16.09 | -16.09 | -16.09 | -16.09 | -16.09 | -16.09 | -16.09 |
| EBITAT | 243.4 | 146.7 | 366.2 | 775.5 | -328.9 | 330.2 | 372.1 | 419.2 | 472.3 | 532.2 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -2,385.8 | -298.3 | -647.5 | -869.6 | -1,039.8 | -662.1 | -1,079.5 | -1,216.3 | -1,370.5 | -1,544.1 |
| WACC, % | 6.2 | 6.04 | 6.4 | 6.37 | 6.79 | 6.36 | 6.36 | 6.36 | 6.36 | 6.36 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -4,793.0 | |||||||||
| Long Term Growth Rate, % | 3.50 | |||||||||
| Free cash flow (T + 1) | -1,598 | |||||||||
| Terminal Value | -55,871 | |||||||||
| Present Terminal Value | -41,047 | |||||||||
| Enterprise Value | -45,840 | |||||||||
| Net Debt | 2,974 | |||||||||
| Equity Value | -48,814 | |||||||||
| Diluted Shares Outstanding, MM | 930 | |||||||||
| Equity Value Per Share | -52.46 |
What You Will Receive
- Authentic Lianhe Chemical Financial Data: Pre-loaded with historical and projected figures for accurate analysis.
- Completely Customizable Template: Easily adjust essential inputs such as revenue growth, WACC, and EBITDA percentages.
- Instantaneous Calculations: Witness real-time updates of Lianhe Chemical’s intrinsic value based on your modifications.
- Professional Valuation Tool: Tailored for investors, analysts, and consultants pursuing precise DCF outcomes.
- User-Friendly Interface: Streamlined layout and straightforward instructions suitable for users of all skill levels.
Key Features
- Customizable Forecast Inputs: Adjust essential factors such as revenue growth, EBITDA margins, and capital expenditures for Lianhe Chemical Technology Co., Ltd. (002250SZ).
- Instant DCF Valuation: Quickly computes intrinsic value, net present value (NPV), and other financial metrics.
- High-Precision Accuracy: Leverages Lianhe Chemical Technology's actual financial data for credible valuation results.
- Effortless Scenario Analysis: Explore various assumptions and evaluate outcomes with ease.
- Efficiency Booster: Remove the hassle of creating complicated valuation models from scratch.
How It Functions
- Download the Template: Gain immediate access to the Excel-based Lianhe Chemical DCF Calculator for [002250SZ].
- Input Your Assumptions: Modify the yellow-highlighted cells to reflect growth rates, WACC, margins, and additional factors.
- Instant Calculations: The model will automatically refresh to display the intrinsic value of Lianhe Chemical.
- Test Scenarios: Experiment with various assumptions to assess potential changes in valuation.
- Analyze and Decide: Utilize the outcomes to inform your investment or financial evaluations.
Reasons to Choose Our Calculator for Lianhe Chemical Technology Co., Ltd. (002250SZ)
- Precision: Utilizes actual financial data from Lianhe Chemical for enhanced accuracy.
- Versatility: Built to allow users the freedom to adjust and experiment with inputs.
- Efficiency: Avoid the complexity of constructing a DCF model from the ground up.
- Expert-Grade: Crafted with the expertise and usability expected at the CFO level.
- Intuitive: Simple to navigate, suitable for users with little to no financial modeling background.
Who Should Use This Product?
- Investors: Evaluate Lianhe Chemical Technology Co., Ltd.'s (002250SZ) valuation before making stock transactions.
- CFOs and Financial Analysts: Enhance valuation workflows and test financial projections for Lianhe Chemical Technology Co., Ltd. (002250SZ).
- Startup Founders: Understand the valuation methods applied to established companies like Lianhe Chemical Technology Co., Ltd. (002250SZ).
- Consultants: Create comprehensive valuation reports for clients involving Lianhe Chemical Technology Co., Ltd. (002250SZ).
- Students and Educators: Utilize real-world data from Lianhe Chemical Technology Co., Ltd. (002250SZ) to practice and teach valuation skills.
Contents of the Template
- Operating and Balance Sheet Data: Pre-filled historical data and forecasts for Lianhe Chemical Technology Co., Ltd. (002250SZ), including metrics such as revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated sheet for calculating the Weighted Average Cost of Capital (WACC), featuring key parameters like Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models that outline intrinsic value with comprehensive calculations.
- Financial Statements: Pre-loaded annual and quarterly financial statements to assist in analysis.
- Key Ratios: Includes critical profitability, leverage, and efficiency ratios for Lianhe Chemical Technology Co., Ltd. (002250SZ).
- Dashboard and Charts: A visual summary of valuation outputs and assumptions, facilitating easy analysis of results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.